EPISODE 9:
Baroness Delyth Morgan
CEO Breast Cancer Now: Achieving more through Collaboration
“Providing support for today and hope for tomorrow.”
Delyth Morgan is the Chief Executive of Breast Cancer Now.
Delyth spent 10 years at Breakthrough Breast Cancer, as the charity’s first Chief Executive, from 1996, before which she worked at Shelter, Workplace Nurseries Campaign and Asthma UK.
After becoming a life peer she was appointed to Government in 2007, when she served as Children’s Minister for the Department of Children Schools and Families, Minister for Intellectual Property and Quality at the Department of Innovation, Universities and Skills and Government spokesperson for the Department of Work and Pensions in the House of Lords.
In 2011, Delyth returned to the field of breast cancer at the helm of Breast Cancer Campaign before going on to become Chief Executive of Breast Cancer Now formed when the charity first merged with Breakthrough Breast Cancer back in spring 2015.
Delyth currently sits in the House of Lords as an independent peer. She is a Fellow of University College London and Honorary Fellow of the Institute of Cancer Research and Cardiff University. She is Patron of Pancreatic Cancer UK and The Sheila McKechnie Foundation and Honorary President of Cancer 52. She also chairs the National Cancer Research Institute (NCRI).
Links
Ep 19. Baroness Delyth Morgan, CEO Breast Cancer Now:
Achieving more through Collaboration
Baroness Delyth Morgan is the CEO of Breast Cancer Now.
Delyth has been leading the charge in the breast cancer space for many years. She is widely credited with achieving consolidation in the sector, having presided over the merger of Breast Cancer Campaign and Breakthrough Breast Cancer in 2015 and the more recent merger of Breast Cancer Now and Breast Cancer Care in 2019.
We discuss the significant progress that has been made in research, treatment and care for breast cancer patients. However, there is still a way to go before Breast Cancer Now can achieve its vision of a future where everyone with breast cancer lives.
We talk about the impact of Brexit on the medical research sector in the UK; and how pandemic-induced delays in cancer diagnosis and treatment, is costing lives.
This conversation is full of Delyth’s wisdom and insights, as she shares her experiences and advice on leadership, on influencing, on collaborating and most important of all, on not giving up hope.
Recorded April 2021.
